Correlation Between Denali Therapeutics and Soleno Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Soleno Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Soleno Therapeutics.
Diversification Opportunities for Denali Therapeutics and Soleno Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Denali and Soleno is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Soleno Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Soleno Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1.28 times more return on investment than Soleno Therapeutics. However, Denali Therapeutics is 1.28 times more volatile than Soleno Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.13 per unit of risk. If you would invest 2,084 in Denali Therapeutics on November 2, 2024 and sell it today you would earn a total of 202.00 from holding Denali Therapeutics or generate 9.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Soleno Therapeutics
Performance |
| Timeline |
| Denali Therapeutics |
| Soleno Therapeutics |
Denali Therapeutics and Soleno Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Soleno Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Soleno Therapeutics vs. Annexon | Soleno Therapeutics vs. Bolt Biotherapeutics | Soleno Therapeutics vs. Lyra Therapeutics | Soleno Therapeutics vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |